Randal W. Scott, CEO, In Vitae Corporation at GENOMIC HEALTH INC (GHDX), sold 30,000 shares at $31.12 ($932K) on 2012-03-13, disclosed to the SEC on 2012-03-14.
Scheduled sale ($932k) by CEO, In Vitae Corporation under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.98 | 15,000 | $465K | 49.9% |
| 2 | $31.12 | 15,000 | $467K | 50.1% |
| Total | $31.05 avg | 30,000 | $932K | 100% |
| Filing → |
| NVTA | SELL | 2019-02-27 | $573K | — | Filing → |
| NVTA | BUY | 2018-04-02 | $200K | — | Filing → |
| NVTA | BUY | 2016-11-22 | $400K | — | Filing → |